Clinical development Tonix Pharmaceuticals Announces That its Single Dose Mpox Vaccine Candidate TNX-801 Aligns with WHO’s Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health Emergency 16 Sep, 2024 5 Late-Stage mRNA Vaccines to Watch 16 Sep, 2024 A vaccine could become a ‘vital’ weapon against pancreatic Read more…
Clinical development Electronic nudges for sustained influenza vaccination uptake in older adults: the nationwide randomized NUDGE-FLU-2 trial 30 Aug, 2024 AIM Vaccine Advances Clinical Trials for New Vaccines 29 Aug, 2024 The long road to a malaria vaccine that’s safe during pregnancy 29 Aug, 2024 First lung cancer vaccine given Read more…
Clinical development CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress 09 Sep, 2024 Delhi govt vaccinates over 50,000 adults with BCG in ongoing trial to combat TB 08 Sep, 2024 Vaxcyte: Stunning PCV Data Readout Suggests Vaccine Maker Is A Strong Buy (PCVX) 06 Read more…
Clinical development Pfizer shares Phase 2 trial update to evaluate second-generation candidates against influenza 19 Aug, 2024 Pipeline Moves: Moderna’s pandemic influenza vaccine trial completes 19 Aug, 2024 Pfizer, BioNTech give update on mRNA-based combination vaccine programme 19 Aug, 2024 LVHN participating in potentially groundbreaking pancreatic cancer vaccine trial. What Read more…
Clinical development Ray of hope as third phase of TB vaccine trial kicks off 22 Jul, 2024 Valneava and Pfizer Nearing Lyme Vaccine Milestone 18 Jul, 2024 BARDA awards up to $500 million for vaccine clinical trials 16 Jul, 2024 Global mRNA Cancer Vaccines Clinical Trials and Market Future Outlook Read more…